• Gene Signatures in Mesothelioma Predict Olaparib and Pemetre

  2026-04-30

  Borchert et al. (2019) identified homologous recombination repair (HRR) gene expression patterns, including BRCAness and BAP1 mutations, as indicators of susceptibility to PARP inhibitor therapy in malignant pleural mesothelioma (MPM). Their findings lay the groundwork for precision chemotherapy research, including the strategic use of pemetrexed in combinatorial regimens targeting DNA repair vulnerabilities.

• Acifran Structural Insights Enable Precision Lipid Metabolis

  2026-04-30

  Explore how Acifran, a selective HM74A/GPR109A and GPR109B agonist, advances lipid metabolism research through cryo-EM–guided structural insights. This article uniquely connects Acifran’s molecular pharmacology to experimental design, setting it apart in the field.

• Hoechst 33258: Precision Bis-Benzimide DNA Staining in Tumor

  2026-04-29

  Hoechst 33258 offers unparalleled sensitivity for DNA staining in both live and fixed cells, empowering advanced analysis of tumor cell pH dynamics and cell cycle status. Its robust fluorescence and AT-rich DNA binding make it the gold standard for fluorescence microscopy and high-throughput flow cytometry in cancer research.

• EV-Transferred ACLY Drives TAM Differentiation in Liver Canc

  2026-04-29

  This study reveals that hepatocellular carcinoma (HCC) cells secrete extracellular vesicles loaded with ATP-citrate lyase (ACLY), which are selectively internalized by monocytes, driving their differentiation into immunosuppressive tumor-associated macrophages (TAMs). Targeting this EV-mediated ACLY transfer provides a mechanistically grounded strategy to enhance immunotherapy efficacy in HCC.

• Apicidin Impairs Oocyte Maturation by Disrupting Meiotic Mac

  2026-04-28

  This study reveals that Apicidin, a fungal mycotoxin and histone deacetylase inhibitor, compromises oocyte quality by disrupting spindle assembly, chromosome alignment, and histone acetylation. The findings highlight the dual role of Apicidin as both a research tool and an environmental contaminant with significant implications for reproductive toxicology and epigenetic research.

• Veratridine: Voltage-Gated Sodium Channel Opener for Researc

  2026-04-28

  Veratridine is a steroidal alkaloid neurotoxin and a potent voltage-gated sodium channel opener. It is widely used in sodium channel dynamics and excitotoxicity studies to model persistent depolarization and neuron injury, offering stable, reproducible effects. As supplied by APExBIO (SKU B7219), Veratridine is validated for precise assay integration in neuroscience and oncology research.

• Regulation of Progenitor Cells in Epithelial Morphogenesis

  2026-04-27

  This article examines Sophie Viala's 2024 doctoral thesis on the molecular regulation of progenitor cells during epithelial morphogenesis and homeostasis. The work delineates novel roles for Gata3 and BMP5 in prostate epithelial stem cell maintenance, with implications for tissue regeneration and tumorigenesis studies.

• 7-Ethyl-10-hydroxycamptothecin: Catalyzing Next-Gen Colon Ca

  2026-04-27

  This thought-leadership article delivers an advanced perspective on 7-Ethyl-10-hydroxycamptothecin (SN-38) as a molecular tool for translational colon cancer research. Integrating mechanistic insights, recent FUBP1 findings, and protocol optimization guidance, it positions APExBIO's offering at the forefront of high-impact, reproducible in vitro workflows. The discussion bridges bench discovery and clinical relevance, offering practical recommendations and a forward-looking outlook.

• Benzyl Quinolone Carboxylic Acid: Optimizing M1 Receptor Ass

  2026-04-26

  Benzyl Quinolone Carboxylic Acid (BQCA) is redefining M1 muscarinic receptor research by enabling precise, bias-selective potentiation of acetylcholine signaling. This guide translates recent mechanistic advances into stepwise workflows, troubleshooting strategies, and benchmarked parameters for cognitive and Alzheimer’s disease research.

• Tubastatin A: HDAC6 Inhibition at the Intersection of Cardia

  2026-04-25

  Explore the multifaceted role of Tubastatin A as a potent HDAC6 inhibitor, uncovering its unique mechanisms in cardiac, neuroprotective, and anti-inflammatory research. This article delivers technical depth, translational insight, and evidence-based protocol guidance to empower advanced biomedical investigations.

• VX-702: Advancing Selective p38α MAPK Inhibition in Translat

  2026-04-24

  Explore how VX-702, a potent p38α MAPK inhibitor, enables next-generation inflammation and cardiovascular studies through precise kinase modulation, unique conformational targeting, and rigorous assay design.

• SERCA Inhibition by BHQ Promotes HSC Mobilization via ER Str

  2026-04-24

  Li et al. (2025) demonstrate that 2,5-di-tert-butylbenzene-1,4-diol (BHQ), a selective SERCA inhibitor, efficiently enhances hematopoietic stem cell (HSC) mobilization by inducing mild endoplasmic reticulum (ER) stress and regulating the CaMKII-STAT3-CXCR4 pathway. This mechanistic insight offers new directions for improving stem cell transplantation protocols and calcium signaling research.

• Pharmacokinetics of Corydalis saxicola Alkaloids in MASH Mod

  2026-04-23

  This study dissects how metabolic dysfunction and liver pathology alter the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids in high-fat, high-cholesterol diet-induced mouse models of MASLD/MASH. The findings highlight the central role of hepatic enzyme and transporter modulation in optimizing dosing strategies for experimental and translational research.

• Nicotinamide Riboside Chloride: Powering RGC and Neurodegene

  2026-04-23

  Nicotinamide Riboside Chloride (NIAGEN) unlocks reproducible NAD+ modulation, driving advanced workflows for metabolic dysfunction and neurodegenerative disease research. This guide details protocol enhancements, troubleshooting strategies, and actionable insights for integrating NIAGEN into retinal ganglion cell (RGC) and Alzheimer's disease models.

• Liproxstatin-1: Ferroptosis Inhibition in Translational Rese

  2026-04-22

  This thought-leadership article explores the mechanistic and translational power of Liproxstatin-1 as a gold-standard ferroptosis inhibitor. Integrating new evidence from salivary gland dysfunction models and advanced lipid peroxidation assays, it provides strategic guidance for researchers seeking to deploy Liproxstatin-1 in disease modeling, protocol optimization, and preclinical innovation. The discussion addresses experimental benchmarks, protocol parameters, and the competitive landscape, while contextualizing APExBIO’s Liproxstatin-1 in the frontier of iron-dependent cell death research.

16622 records 1/1109 page Next 12345 下5页 Last page